MPM Capital
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
20Deep-tech portfolio11 active
9Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Crossbow Therapeutics
23Co-investorsShare a portfolio company
Portfolio · 20 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Crossbow Therapeutics | Biotech | Active | Sep 30, 2025 | $67.8M |
| Reunion Neuroscience | Biotech | Active | Sep 9, 2025 | $16.9M |
| Arialys Therapeutics | Biotech | Active | Jul 1, 2025 | $29.1M |
| Antiva Biosciences | Biotech | Active | Oct 11, 2024 | $80.6M |
| NextPoint Therapeutics | Biotech | Active | Feb 14, 2024 | $122.5M |
| Umoja Biopharma | Biotech | Active | Jun 24, 2021 | $210.0M |
| ashibio | Biotech | Active | — | — |
| AstronauTx | Biotech | Active | — | — |
| DBV Technologies | Medtech | Active | — | — |
| Seawolf Therapeutics | Biotech | Active | — | — |
| Twentyeight-Seven Therapeutics | Biotech | Active | — | — |
| Aktis Oncology | Biotech | Public | Oct 2, 2024 | $175.0M |
| Cidara Therapeutics | Biotech | Acquired | May 6, 2024 | $349.1M |
| Dyne Therapeutics | Biotech | Public | Aug 14, 2020 | $115.7M |
| iTeos Therapeutics | Biotech | Acquired | Apr 9, 2020 | $125.4M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
| Aldeyra Therapeutics | Biotech | Public | Feb 11, 2019 | $24.6M |
| Cullinan Therapeutics | Biotech | Public | — | — |
| Orna Therapeutics | Biotech | Acquired | — | — |
| Repare Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#16
Portfolio exits#13
Raises, 12 months#88
Co-investors#90
Co-investors
- MPM BioImpactVenture capital4 shared
- Atlas VentureVenture capital2 shared
- Avalon VenturesVenture capital2 shared
- Clarus VenturesVenture capital1 shared
- Domain AssociatesVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- Gurnet Point CapitalVenture capital1 shared
- GVVenture capital1 shared
- H.I.G. BioHealth PartnersVenture capital1 shared
- ModernaVenture capital1 shared
Sectors
- Biotech19
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.